**The rapid expansion of the 2026 Bundibugyo Ebola outbreak across the Democratic Republic of the Congo, now the country’s largest and second-biggest globally, underpins the 71% market-implied odds for a new country reporting a confirmed case before October 1.** Unprecedented speed—surpassing 5,000 cases and 2,600 deaths in roughly 100 days—combined with the rare strain lacking approved vaccines or treatments, sustained community transmission outside contact-tracing networks, and challenges from conflict zones, mining corridors, and health-worker strikes have traders pricing in elevated cross-border risk. Spread to six provinces, proximity to borders with South Sudan and others, and historical patterns of imported cases (Uganda and France earlier in the outbreak) add momentum, though Uganda’s July declaration of being Ebola-free and limited international exports provide some counterbalance. Key near-term catalysts include ongoing case growth, any travel-related detections, and the effectiveness of scaled response efforts through early fall.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedEbola: new country confirmed before October 1?
Ebola: new country confirmed before October 1?
71% chance
NEW
NEW
Sep 30, 2026
71% chance
NEW
NEW
Sep 30, 2026
This market will resolve to "Yes" if, at any point between market creation and September 30, 2026, 11:59 PM ET., a confirmed case of Ebola is reported in a country that had not reported any confirmed Ebola case in the current outbreak as of market creation. Otherwise, this market will resolve to "No".
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.**The rapid expansion of the 2026 Bundibugyo Ebola outbreak across the Democratic Republic of the Congo, now the country’s largest and second-biggest globally, underpins the 71% market-implied odds for a new country reporting a confirmed case before October 1.**
Unprecedented speed—surpassing 5,000 cases and 2,600 deaths in roughly 100 days—combined with the rare strain lacking approved vaccines or treatments, sustained community transmission outside contact-tracing networks, and challenges from conflict zones, mining corridors, and health-worker strikes have traders pricing in elevated cross-border risk. Spread to six provinces, proximity to borders with South Sudan and others, and historical patterns of imported cases (Uganda and France earlier in the outbreak) add momentum, though Uganda’s July declaration of being Ebola-free and limited international exports provide some counterbalance. Key near-term catalysts include ongoing case growth, any travel-related detections, and the effectiveness of scaled response efforts through early fall.
This market will resolve to "Yes" if, at any point between market creation and September 30, 2026, 11:59 PM ET., a confirmed case of Ebola is reported in a country that had not reported any confirmed Ebola case in the current outbreak as of market creation. Otherwise, this market will resolve to "No".
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.
Market Opened: Aug 13, 2026, 2:16 PM ET
Volume
$132End Date
Oct 1, 2026Market Opened
Aug 13, 2026, 2:16 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if, at any point between market creation and September 30, 2026, 11:59 PM ET., a confirmed case of Ebola is reported in a country that had not reported any confirmed Ebola case in the current outbreak as of market creation. Otherwise, this market will resolve to "No".
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.**The rapid expansion of the 2026 Bundibugyo Ebola outbreak across the Democratic Republic of the Congo, now the country’s largest and second-biggest globally, underpins the 71% market-implied odds for a new country reporting a confirmed case before October 1.**
Unprecedented speed—surpassing 5,000 cases and 2,600 deaths in roughly 100 days—combined with the rare strain lacking approved vaccines or treatments, sustained community transmission outside contact-tracing networks, and challenges from conflict zones, mining corridors, and health-worker strikes have traders pricing in elevated cross-border risk. Spread to six provinces, proximity to borders with South Sudan and others, and historical patterns of imported cases (Uganda and France earlier in the outbreak) add momentum, though Uganda’s July declaration of being Ebola-free and limited international exports provide some counterbalance. Key near-term catalysts include ongoing case growth, any travel-related detections, and the effectiveness of scaled response efforts through early fall.
This market will resolve to "Yes" if, at any point between market creation and September 30, 2026, 11:59 PM ET., a confirmed case of Ebola is reported in a country that had not reported any confirmed Ebola case in the current outbreak as of market creation. Otherwise, this market will resolve to "No".
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.
The "current outbreak" is the Bundibugyo ebolavirus outbreak declared by the DRC on May 15, 2026. A "qualifying country" is any country other than the Democratic Republic of the Congo, Uganda, or France, each of which had recorded at least one confirmed case attributable to this outbreak as reported by Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/ebola/situation-summary/index.html.
A "confirmed case" is a laboratory-confirmed Bundibugyo ebolavirus infection attributed to the current outbreak. A case counts for whichever country the qualifying source assigns it to in its reporting, regardless of where exposure, symptom onset, or specimen collection occurred. Resolution turns on the date a qualifying source publishes the confirmation — not the date of exposure, onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier.
The primary resolution sources for this market will be official information from the relevant national and international health authorities, including CDC and the World Health Organization (WHO); however, an overwhelming consensus of credible reporting will also suffice.
Volume
$132End Date
Oct 1, 2026Market Opened
Aug 13, 2026, 2:16 PM ETResolver
0x65070BE91...**The rapid expansion of the 2026 Bundibugyo Ebola outbreak across the Democratic Republic of the Congo, now the country’s largest and second-biggest globally, underpins the 71% market-implied odds for a new country reporting a confirmed case before October 1.** Unprecedented speed—surpassing 5,000 cases and 2,600 deaths in roughly 100 days—combined with the rare strain lacking approved vaccines or treatments, sustained community transmission outside contact-tracing networks, and challenges from conflict zones, mining corridors, and health-worker strikes have traders pricing in elevated cross-border risk. Spread to six provinces, proximity to borders with South Sudan and others, and historical patterns of imported cases (Uganda and France earlier in the outbreak) add momentum, though Uganda’s July declaration of being Ebola-free and limited international exports provide some counterbalance. Key near-term catalysts include ongoing case growth, any travel-related detections, and the effectiveness of scaled response efforts through early fall.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions